{"friendlyName": "Triplegen Stage", "units": [{"evidence": "HOXC10: Pathology\nHOXC10 is overexpressed in breast cancer and transcriptionally regulated by estrogen via involvement of histone methylases MLL3 and MLL4.\nMethylation of the estrogen-repressed gene HOXC10 in breast cancer determines resistance to aromatase inhibitors. This epigenetic reprogramming of HOXC10 is observed in endocrine-resistant breast cancer.\n", "description": "HOXC10 is related to the following Pathology: overexpressed, aromatase inhibitors.", "statements": [["<http://dbpedia.org/resource/HOXC10>", "<http://www.w3.org/2004/02/skos/core#related>", "<https://calvoritmo.com/tfm/entity/ed98e4b7-e2c0-4d2a-a8c6-31701d38b353>"], ["<http://dbpedia.org/resource/Pathology>", "<http://www.w3.org/2004/02/skos/core#narrower>", "<https://calvoritmo.com/tfm/entity/ed98e4b7-e2c0-4d2a-a8c6-31701d38b353>"], ["<https://calvoritmo.com/tfm/entity/ed98e4b7-e2c0-4d2a-a8c6-31701d38b353>", "<http://www.w3.org/2000/01/rdf-schema#label>", "Pathology of HOXC10"], ["<https://calvoritmo.com/tfm/entity/ed98e4b7-e2c0-4d2a-a8c6-31701d38b353>", "<http://www.w3.org/2004/02/skos/core#narrower>", "<http://dbpedia.org/resource/Gene_overexpression?action=edit&redlink=1>"], ["<http://dbpedia.org/resource/Gene_overexpression?action=edit&redlink=1>", "<http://www.w3.org/2000/01/rdf-schema#label>", "overexpressed"], ["<https://calvoritmo.com/tfm/entity/ed98e4b7-e2c0-4d2a-a8c6-31701d38b353>", "<http://www.w3.org/2004/02/skos/core#narrower>", "<http://dbpedia.org/resource/Aromatase_inhibitor>"], ["<http://dbpedia.org/resource/Aromatase_inhibitor>", "<http://www.w3.org/2000/01/rdf-schema#label>", "aromatase inhibitors"]]}]}